Triple

T12109695
Position Surface form Disambiguated ID Type / Status
Subject Wilder E288390 entity
Predicate hasNotableBearer P458 FINISHED
Object Wilder Penfield E764623 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Wilder Penfield | Statement: [Wilder, hasNotableBearer, Wilder Penfield]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Wilder Penfield
Context triple: [Wilder, hasNotableBearer, Wilder Penfield]
  • A. Wilder Penfield chosen
    Wilder Penfield was a pioneering Canadian neurosurgeon and neuroscientist renowned for his groundbreaking brain-mapping studies and contributions to epilepsy surgery.
  • B. George Kassabaum
    George Kassabaum was an American architect and co-founder of the global design and architecture firm HOK.
  • C. Henri Gastaut
    Henri Gastaut was a prominent French neurologist and epileptologist known for his major contributions to the classification and understanding of epilepsy.
  • D. André Broca
    André Broca was a 19th-century French physician and anatomist known for his contributions to the study of the nervous system and pathology.
  • E. Karl Lashley
    Karl Lashley was an influential American psychologist and neuroscientist known for his pioneering research on brain function, learning, and memory, particularly through lesion studies in animals.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6ab4a5c448190a110d1273314b21a completed April 8, 2026, 7:23 p.m.
NER Named-entity recognition batch_69d9156709288190b4684cb19037dc38 completed April 10, 2026, 3:21 p.m.
NED1 Entity disambiguation (via context triple) batch_69f5f67b3f2c8190bcb2120781f91220 completed May 2, 2026, 1:04 p.m.
Created at: April 8, 2026, 9:49 p.m.